Format

Send to

Choose Destination
  • The following term was not found in PubMed: Apr;87.
Catheter Cardiovasc Interv. 2016 Apr;87(5):963-70. doi: 10.1002/ccd.26266. Epub 2015 Oct 22.

Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.

Author information

1
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
2
Division of Cardiology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
3
Division of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Japan.
4
Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.
5
Department of Interventional Cardiology, Institut Cardiovasculaire Paris Sud, Massy, France.
6
Department of Cardiovascular Surgery, Keio University School of Medicine, Tokyo, Japan.

Abstract

BACKGROUNDS:

To facilitate the learning process of transcatheter aortic valve implantation (TAVI) in Japan, unique supporting systems (e.g., on-site proctor and web-based screening systems) have been developed. Nevertheless, little is known about real-world clinical outcomes after TAVI in Japan compared with their European counterparts.

METHODS:

From the optimized catheter valvular intervention (OCEAN-TAVI, Japan) and the Institut Cardiovasculaire Paris Sud (Massy, France) registries, we evaluated a total of 134 and 178 patients, respectively, who underwent transfemoral TAVI during the same time period.

RESULTS:

Among the French cohort, about half of the patients (N = 81, 45.5%) were treated with the Edwards SAPIEN XT. Body surface area was significantly smaller in the Japanese cohort, although operative risks for both cohorts were almost the same. A greater percentage of patients in the Japanese cohort were implanted with 23 mm valves compared with the French cohort (73.1% vs. 23.0%, P < 0.001), reflecting the smaller annulus diameter (21.8 ± 1.6 vs. 23.8 ± 2.4 mm, P < 0.001). All-cause 30-day mortality (0% vs. 0.6%, P = 1.000) and 30-day combined safety endpoint based on the Valve Academic Research Consortium 2 (VARC2) criteria (9.7% vs. 11.2%, P = 0.713) were similar when limiting the analysis to patients treated with the Edwards SAPIEN XT.

CONCLUSIONS:

Despite the unfavorable aortic anatomy of the Japanese patients, their clinical outcomes after transfemoral TAVI were excellent with the same degree of safety as in an experienced European institute. This minimized learning process achieved the use of unique support systems.

KEYWORDS:

ethnicity; outcome; transcatheter aortic valve implantation

PMID:
26489980
DOI:
10.1002/ccd.26266
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center